Chapter 19 New Therapy for Neuropathic Pain

International Review of Neurobiology

Volumn 85, Issue , 2009, Pages 249-260

  Mizoguchi, Hirokazu ^a   Watanabe, Chizuko ^a   Yonezawa, Akihiko ^a   Sakurada, Shinobu ^a  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; DIZOCILPINE; DYNORPHIN A; ENDOMORPHIN 2; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; FENTANYL; GABAPENTIN; KETAMINE; METHADONE; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OPIATE AGONIST; OXYCODONE; PLACEBO; PROTEIN KINASE C INHIBITOR; SODIUM CHANNEL BLOCKING AGENT; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED SODIUM CHANNEL; NARCOTIC AGENT; NEW DRUG;

ALLODYNIA; ANALGESIA; CANCER PAIN; CHRONIC INFLAMMATION; CHRONIC PAIN; CLINICAL TRIAL; DIABETIC NEUROPATHY; DIZZINESS; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG RECEPTOR BINDING; HEROIN DEPENDENCE; HUMAN; HYPERALGESIA; MENTAL DISEASE; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PERIPHERAL EDEMA; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REVIEW; SOMNOLENCE; ANIMAL; DISEASE MODEL; DRUG EFFECT; DRUG RESISTANCE; NEURALGIA; PATHOPHYSIOLOGY; PHYSIOLOGY; SPINAL CORD;

ANIMALS; DISEASE MODELS, ANIMAL; DRUG RESISTANCE; DRUGS, INVESTIGATIONAL; HUMANS; NARCOTICS; NEURALGIA; SPINAL CORD;

EID: 67650082998     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(09)85019-8     Document Type: Review

References (73)

1. Alford D.P., Compton P., and Samet J.H. Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Ann. Intern. Med. 144 (2006) 127-134
2. Arnér S., and Meyerson B.A. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 33 (1988) 11-23
3. Bennett G.J., and Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33 (1988) 87-107
4. Bian D., Nichols M.L., Ossipov M.H., Lai J., and Porreca F. Characterization of the antiallodynic efficacy of morphine in a model of neuropathic pain in rats. Neuroreport 6 (1995) 1981-1984
5. Chen S.R., and Pan H.L. Antinociceptive effect of morphine, but not mu opioid receptor number, is attenuated in the spinal cord of diabetic rats. Anesthesiology 99 (2003) 1409-1414
6. Chen S.R., Sweigart K.L., Lakoski J.M., and Pan H.L. Functional mu opioid receptors are reduced in the spinal cord dorsal horn of diabetic rats. Anesthesiology 97 (2002) 1602-1608
7. Courteix C., Bourget P., Caussade F., Bardin M., Coudore F., Fialip J., and Eschalier A. Is the reduced efficacy of morphine in diabetic rats caused by alterations of opiate receptors or of morphine pharmacokinetics?. J. Pharmacol. Exp. Ther. 285 (1998) 63-70
8. Covington E.C. Anticonvulsants for neuropathic pain and detoxification. Cleve. Clin. J. Med. 65 Suppl. 1 (1998) S121-S129 S145-S147
9. DeGroot J.F., Coggeshall R.E., and Carlton S.M. The reorganization of mu opioid receptors in the rat dorsal horn following peripheral axotomy. Neurosci. Lett. 233 (1997) 113-116
10. Dworkin R.H., Backonja M., Rowbotham M.C., Allen R.R., Argoff C.R., Bennett G.J., Bushnell M.C., Farrar J.T., Galer B.S., Haythornthwaite J.A., Hewitt D.J., Loeser J.D., et al. Advances in neuropathic pain: Diagnosis, mechanisms, and treatment recommendations. Arch. Neurol. 60 (2003) 1524-1534
11. Dworkin R.H., O'Connor A.B., Backonja M., Farrar J.T., Finnerup N.B., Jensen T.S., Kalso E.A., Loeser J.D., Miaskowski C., Nurmikko T.J., Portenoy R.K., Rice A.S.C., et al. Pharmacologic management of neuropathic pain: Evidence-based recommendations. Pain 132 (2007) 237-251
12. Eisenberg E., McNicol E.D., and Carr D.B. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: Systematic review and meta-analysis of randomized controlled trials. JAMA 293 (2005) 3043-3052
13. Eisenberg E., McNicol E.D., and Carr D.B. Efficacy of mu-opioid agonists in the treatment of evoked neuropathic pain: Systematic review of randomized controlled trials. Eur. J. Pain 10 (2006) 667-676
14. Gabra B.H., and Sirois P. Hyperalgesia in non-obese diabetic (NOD) mice: A role for the inducible bradykinin B1 receptor. Eur. J. Pharmacol. 514 (2005) 61-67
15. Gilron I., Biederman J., Jhamandas K., and Hong M. Gabapentin blocks and reverses antinociceptive morphine tolerance in the rat pawpressure and tail-flick tests. Anesthesiology 98 (2003) 1288-1292
16. Gorman A.L., Elliott K.J., and Inturrisi C.E. The d- and l-isomers of methadone bind to the non-competitive site on the N-methyl d-aspartate (NMDA) receptor in rat forebrain and spinal cord. Neurosci. Lett. 223 (1997) 5-8
17. Gracely R.H., Lynch S.A., and Bennett G.J. Painful neuropathy: Altered central processing maintained dynamically by peripheral input. Pain 51 (1992) 175-194
18. Grass S., Hoffmann O., Xu X.J., and Wiesenfeld-Hallin Z. N-methyl-d-aspartate receptor antagonists potentiate morphine's antinociceptive effect in the rat. Acta Physiol. Scand. 158 (1996) 269-273
19. Hains B.C., Saab C.Y., Klein J.P., Craner M.J., and Waxman S.G. Altered sodium channel expression in second-order spinal sensory neurons contributes to pain after peripheral nerve injury. J. Neurosci. 24 (2004) 4832-4839
20. Honore P., Rogers S.D., Schwei M.J., Salak-Johnson J.L., Luger N.M., Sabino M.C., Clohisy D.R., and Mantyh P.W. Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons. Neuroscience 98 (2000) 585-598
21. Hylden J.L., Thomas D.A., Iadarola M.J., Nahin R.L., and Dubner R. Spinal opioid analgesic effects are enhanced in a model of unilateral inflammation/hyperalgesia: Possible involvement of noradrenergic mechanisms. Eur. J. Pharmacol. 194 (1991) 135-143
22. Kajander K.C., Sahara Y., Iadarola M.J., and Bennett G.J. Dynorphin increases in the dorsal spinal cord in rats with a painful peripheral neuropathy. Peptides 11 (1990) 719-728
23. Kalso E., Edwards J.E., Moore R.A., and McQuay H.J. Opioids in chronic non-cancer pain: Systematic review of efficacy and safety. Pain 112 (2004) 372-380
24. Kim S.H., and Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50 (1992) 355-363
25. Kim H.S., Jang C.G., and Park W.K. Inhibition by MK-801 of morphineinduced conditioned place preference and postsynaptic dopamine receptor supersensitivity in mice. Pharmacol. Biochem. Behav. 55 (1996) 11-17
26. Lee Y.W., Chaplan S.R., and Yaksh T.L. Systemic and supraspinal, but not spinal, opiates suppress allodynia in a rat neuropathic pain model. Neurosci. Lett. 199 (1995) 111-114
27. Lemberg K.K., Kontinen V.K., Siiskonen A.O., Viljakka K.M., Yli-Kauhaluoma J.T., Korpi E.R., and Kalso E.A. Antinociception by spinal and systemic oxycodone: Why does the route make a difference? In vitro and in vivo studies in rats. Anesthesiology 105 (2006) 801-812
28. Luger N.M., Sabino M.A., Schwei M.J., Mach D.B., Pomonis J.D., Keyser C.P., Rathbun M., Clohisy D.R., Honore P., Yaksh T.L., and Mantyh P.W. Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs. inflammatory pain. Pain 99 (2002) 397-406
29. Mao J., Price D.D., Hayes R.L., Lu J., and Mayer D.J. Differential roles of NMDA and non-NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathy. Brain Res. 598 (1992) 271-278
30. Mao J., Price D.D., and Mayer D.J. Experimental mononeuropathy reduces the antinociceptive effects of morphine: Implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain. Pain 61 (1995) 353-364
31. Mao J., Price D.D., Phillips L.L., Lu J., and Mayer D.J. Increases in protein kinase C gamma immunoreactivity in the spinal cord dorsal horn of rats with painful mononeuropathy. Neurosci. Lett. 198 (1995) 75-78
32. Max M.B. Towards physiologically based treatment of patients with neuropathic pain. Pain 42 (1990) 131-137
33. 1-opioid receptors in spinal antinociception by endomorphin-2. J. Pharmacol. Exp. Ther. 317 (2006) 362-368
34. Mizoguchi H., Watanabe C., Watanabe H., Moriyama K., Sato B., Ohwada K., Yonezawa A., Sakurada T., and Sakurada S. Involvement of endogenous opioid peptides in the antinociception induced by the novel dermorphin tetrapeptide analog amidino-TAPA. Eur. J. Pharmacol. 560 (2007) 150-159
35. Moulin D.E., Palma D., Watling C., and Schulz V. Methadone in the management of intractable neuropathic noncancer pain. Can. J. Neurol. Sci. 32 (2005) 340-343
36. Narita M., Yajima Y., Aoki T., Ozaki S., Mizoguchi H., Tseng L.F., and Suzuki T. Up-regulation of the TrkB receptor in mice injured by the partial ligation of the sciatic nerve. Eur. J. Pharmacol. 401 (2000) 187-190
37. Narita M., Kuzumaki N., Suzuki M., Narita M., Oe K., Yamazaki M., Yajima Y., and Suzuki T. Increased phosphorylated-mu-opioid receptor immunoreactivity in the mouse spinal cord following sciatic nerve ligation. Neurosci. Lett. 354 (2004) 148-152
38. Narita M., Nakajima M., Miyoshi K., Narita M., Nagumo Y., Miyatake M., Yajima Y., Yanagida K., Yamazaki M., and Suzuki T. Role of spinal voltage-dependent calcium channel alpha 2 delta-1 subunit in the expression of a neuropathic pain-like state in mice. Life Sci. 80 (2007) 2015-2024
39. Narita M., Nakamura A., Ozaki M., Imai S., Miyoshi K., Suzuki M., and Suzuki T. Comparative pharmacological profiles of morphine and oxycodone under a neuropathic pain-like state in mice: Evidence for less sensitivity to morphine. Neuropsychopharmacology 33 (2008) 1097-1112
40. Nielsen C.K., Ross F.B., and Smith M.T. Incomplete, asymmetric, and route-dependent cross-tolerance between oxycodone and morphine in the Dark Agouti rat. J. Pharmacol. Exp. Ther. 295 (2000) 91-99
41. Nielsen C.K., Ross F.B., Lotfipour S., Saini K.S., Edwards S.R., and Smith M.T. Oxycodone and morphine have distinctly different pharmacological profiles: Radioligand binding and behavioural studies in two rat models of neuropathic pain. Pain 132 (2007) 289-300
42. α-amidino-Tyr-d-Arg-Phe-MeβAla-OH (ADAMB). J. Med. Chem. 45 (2002) 5081-5089
43. Okon T. Ketamine: An introduction for the pain and palliative medicine physician. Pain Physician 10 (2007) 493-500
44. Okuse K., Chaplan S.R., McMahon S.B., Luo Z.D., Calcutt N.A., Scott B.P., Akopian A.N., and Wood J.N. Regulation of expression of the sensory neuron-specific sodium channel SNS in inflammatory and neuropathic pain. Mol. Cell. Neurosci. 10 (1997) 196-207
45. Ossipov M.H., Lopez Y., Nichols M.L., Bian D., and Porreca F. Inhibition by spinal morphine of the tail-fick response is attenuated in rats with nerve ligation injury. Neurosci. Lett. 199 (1995) 83-86
46. Pollack M.H., Matthews J., and Scott E.L. Gabapentin as a potential treatment for anxiety disorders. Am. J. Psychiatry 155 (1998) 992-993
47. Porreca F., Tang Q.B., Bian D., Riedl M., Elde R., and Lai J. Spinal opioid mu receptor expression in lumbar spinal cord of rats following nerve injury. Brain Res. 795 (1998) 197-203
48. Portenoy R.K., Foley K.M., and Inturrisi C.E. The nature of opioid responsiveness and its implications for neuropathic pain: New hypotheses derived from studies of opioid infusions. Pain 43 (1990) 273-286
49. Przewlocka B., Mika J., Labuz D., Toth G., and Przewlocki R. Spinal analgesic action of endomorphins in acute, inflammatory and neuropathic pain in rats. Eur. J. Pharmacol. 367 (1999) 189-196
50. Rashid M.H., and Ueda H. Nonopioid and neuropathy-specific analgesic action of the nootropic drug nefiracetam in mice. J. Pharmacol. Exp. Ther. 303 (2002) 226-231
51. Rhodin A., Grönbladh L., Nilsson L.H., and Gordh T. Methadone treatment of chronic non-malignant pain and opioid dependence-a long-term follow-up. Eur. J. Pain 10 (2006) 271-278
52. Roberts R.E., and McLean W.G. Protein kinase C isozyme expression in sciatic nerves and spinal cords of experimentally diabetic rats. Brain Res. 754 (1997) 147-156
53. Rose M.A., and Kam P.C. Gabapentin: Pharmacology and its use in pain management. Anaesthesia 57 (2002) 451-462
54. Sakurada S., Hayashi T., Yuhki M., Orito T., Zadina J.E., Kastin A.J., Fujimura T., Murayama K., Sakurada C., Sakurada T., Narita M., Suzuki T., et al. Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse. Eur. J. Pharmacol. 427 (2001) 203-210
55. Scott D.A., Wright C.E., and Angus J.A. Actions of intrathecal omega-conotoxins CVID, GVIA, MVIIA, and morphine in acute and neuropathic pain in the rat. Eur. J. Pharmacol. 451 (2002) 279-286
56. Shimoyama M., Tanaka K., Hasue F., and Shimoyama N. A mouse model of neuropathic cancer pain. Pain 99 (2002) 167-174
57. Shir Y., and Seltzer Z. A-fibers mediate mechanical hyperesthesia and allodynia and C-fibers mediate thermal hyperalgesia in a new model of causalgiform pain disorders in rats. Neurosci. Lett. 115 (1990) 62-67
58. Sindrup S.H., and Jensen T.S. Efficacy of pharmacological treatments of neuropathic pain: An update and effect related to mechanism of drug action. Pain 83 (1999) 389-400
59. Takasaki I., Andoh T., Nitta M., Takahata H., Nemoto H., Shiraki K., Nojima H., and Kuraishi Y. Pharmacological and immunohistochemical characterization of a mouse model of acute herpetic pain. Jpn. J. Pharmacol. 83 (2000) 319-326
60. Takasaki I., Andoh T., Shiraki K., and Kuraishi Y. Allodynia and hyperalgesia induced by herpes simplex virus type-1 infection in mice. Pain 86 (2000) 95-101
61. 2-δ proteins. CNS Drug Rev. 10 (2004) 183-188
62. Trujillo K.A., and Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251 (1991) 85-87
63. Vanderah T.W., Gardell L.R., Burgess S.E., Ibrahim M., Dogrul A., Zhong C.M., Zhang E.T., Malan Jr. T.P., Ossipov M.H., Lai J., and Porreca F. Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance. J. Neurosci. 20 (2000) 7074-7079
64. Wang Z., Gardell L.R., Ossipov M.H., Vanderah T.W., Brennan M.B., Hochgeschwender U., Hruby V.J., Malan Jr. T.P., Lai J., and Porreca F. Pronociceptive actions of dynorphin maintain chronic neuropathic pain. J. Neurosci. 21 (2001) 1779-1786
65. Watson C.P.N., and Babul N. Efficacy of oxycodone in neuropathic pain: A randomized trial in postherpetic neuralgia. Neurology 50 (1998) 1837-1841
66. Watson C.P., Moulin D., Watt-Watson J., Gordon A., and Eisenhoffer J. Controlled-release oxycodone relieves neuropathic pain: A randomized controlled trial in painful diabetic neuropathy. Pain 105 (2003) 71-78
67. 3H]MK-801 labels a site on the N-methyl-d-aspartate receptor channel complex in rat brain membranes. J. Neurochem. 50 (1988) 274-281
68. Yajima Y., Narita M., Shimamura M., Narita M., Kubota C., and Suzuki T. Differential involvement of spinal protein kinase C and protein kinase A in neuropathic and inflammatory pain in mice. Brain Res. 992 (2003) 288-293
69. Yajima Y., Narita M., Usui A., Kaneko C., Miyatake M., Narita M., Yamaguchi T., Tamaki H., Wachi H., Seyama Y., and Suzuki T. Direct evidence for the involvement of brain-derived neurotrophic factor in the development of a neuropathic pain-like state in mice. J. Neurochem. 93 (2005) 584-594
70. Yang L., Zhang F.X., Huang F., Lu Y.J., Li G.D., Bao L., Xiao H.S., and Zhang X. Peripheral nerve injury induces trans-synaptic modification of channels, receptors and signal pathways in rat dorsal spinal cord. Eur. J. Neurosci. 19 (2004) 871-883
71. Yarnitsky D., and Eisenberg E. Neuropathic pain: Between positive and negative ends. Pain Forum 7 (1998) 241-242
72. Zhang W., Slusher B., Murakawa Y., Wozniak K.M., Tsukamoto T., Jackson P.F., and Sima A.A. GCPII (NAALADase) inhibition prevents long-term diabetic neuropathy in type 1 diabetic BB/Wor rats. J. Neurol. Sci. 194 (2002) 21-28
73. Zurek J.R., Nadeson R., and Goodchild C.S. Spinal and supraspinal components of opioid antinociception in streptozotocin induced diabetic neuropathy in rats. Pain 90 (2001) 57-63